Health Care Resource Utilization Over Time in Patients with Psoriatic Disease, Stratified by BMI

Main Article Content

Stephen Shields
American Medical Group Association (AMGA), Alexandria, Virginia, USA

Ann Von Holle
American Medical Group Association (AMGA), Alexandria, Virginia, USA

Rachael Zuckerman
American Medical Group Association (AMGA), Alexandria, Virginia, USA

Russel Burge
Eli Lilly and Company, Indianapolis, Indiana, USA; University of Cincinnati, Cincinnati, Ohio, USA

Beth Mitchell
Eli Lilly and Company, Indianapolis, Indiana, USA

Susan Ball
Eli Lilly and Company, Indianapolis, Indiana, USA

Joseph F. Merola
UT Southwestern Medical Center, Dallas, Texas, USA

Elizabeth Ciemins
American Medical Group Association (AMGA), Alexandria, Virginia, USA

Keywords

Psoriatic Disease, BMI, healthcare resource utilization, Psoriasis, psoriatic arthritis, Obesity

References

1. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. 2021;157(8). doi:10.1001/jamadermatol.2021.2007.

2. Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. The BMJ. 2020;369. doi:10.1136/bmj.m1590Kompala, T. and A. Neinstein, A new era: increasing continuous glucose monitoring use in type 2 diabetes. Am J Manag Care, 2019. 25(4 Spec No.): p. Sp123-sp126.

3. Budu-Aggrey A, Brumpton B, Tyrrell J, et al. Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS Med. 2019;16(1). doi:10.1371/journal.pmed.1002739

4. Love TJ, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: A population-based study. Ann Rheum Dis. 2012;71(8). doi:10.1136/annrheumdis-2012-201299

Article Sidebar

PDF
Published
2025-11-10
DOI: https://doi.org/10.25251/9rcsyb98

Article Details

How to Cite
1.
Health Care Resource Utilization Over Time in Patients with Psoriatic Disease, Stratified by BMI. J of Skin. 2025;9(6):s640. doi:10.25251/9rcsyb98
Issue
Vol. 9 No. 6 (2025): November 2025 Issue
Section
Psoriasis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 4 > >>